GlassScriptPhysician profile
Vidhya Subramanian
NPI 1295752004
$12,920.63
in general payments reported to CMS, 2019-2025
47 companies · $4,842 in 2025
The $4,842 reported for 2025 was more than what 87% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $226 · 2021: $71.93 · 2022: $576 · 2023: $3,220 · 2024: $3,426 · 2025: $4,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Gift: $59.40 · Education: $39.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,388.86 |
| Gift | $59.40 |
| Education | $39.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,348.16 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $1,244.75 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $1,075.50 | 2020-2025 | Evenity, Prolia, Tepezza |
| Mannkind Corporation | $680.26 | 2023-2025 | Afrezza |
| Insulet Corporation | $600.69 | 2024-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $586.28 | 2019-2025 | |
| Dexcom, INC. | $574.11 | 2023-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $518.27 | 2022-2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $500.14 | 2019-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $443.83 | 2023-2025 | |
| Corcept Therapeutics | $428.02 | 2024-2025 | Korlym |
| Abbvie INC. | $420.66 | 2023-2025 | Synthroid |
| Tandem Diabetes Care, INC. | $418.02 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $373.04 | 2022-2025 | Jardiance, Synjardy |
| Alexion Pharmaceuticals, INC. | $350.49 | 2022-2025 | Strensiq |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $349.35 | 2022-2025 | Unithroid |
| Avvisto Therapeutics, LLC | $293.28 | 2025 | Cycloset |
| Ascendis Pharma Endocrinology INC | $270.15 | 2023-2025 | Yorvipath |
| Antares Pharma, INC. | $265.78 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Embecta Corp. | $213.77 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Beta Bionics, INC. | $212.14 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Cequr Corporation | $183.50 | 2023-2025 | Cequr Simplicity |
| Abbott Laboratories | $165.30 | 2019-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $147.71 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Medtronic, INC. | $140.21 | 2023 | Minimed 780g, Intellis Adaptivestim |
| Madrigal Pharmaceuticals | $117.73 | 2024-2025 | Resmetirom, Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.62 | 2023-2024 | Cycloset |
| Acella Pharmaceuticals, LLC | $73.65 | 2024-2025 | NP Thyroid 60 |
| Tolmar, INC. | $68.09 | 2023-2025 | Jatenzo |
| Ibsa Pharma INC. | $67.27 | 2023-2025 | Flector, Licart, Tirosint |
| Novartis Pharmaceuticals Corporation | $63.71 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $61.71 | 2025 | |
| Verity Pharmaceuticals INC. | $57.00 | 2024-2025 | Tlando |
| Horizon Therapeutics Plc | $55.71 | 2022-2023 | Tepezza |
| Ascensia Diabetes Care US INC. | $55.06 | 2024-2025 | |
| Kyowa Kirin, INC. | $53.16 | 2024 | Crysvita |
| Sequel Med Tech, LLC | $52.05 | 2025 | Twiist |
| Echosens North America, INC. | $45.54 | 2025 | Fibroscan |
| Esperion Therapeutics, INC. | $41.63 | 2023-2024 | Nexletol |
| Ultragenyx Pharmaceutical INC. | $34.13 | 2024 | Crysvita |
| Currax Pharmaceuticals LLC | $33.45 | 2021-2025 | Contrave |
| Averitas Pharma INC. | $29.69 | 2023 | Qutenza |
| Alvogen INC | $25.95 | 2025 | Teriparatide |
| Evoke Pharma, INC. | $21.64 | 2025 | |
| Recordati_rare_diseases_inc. | $20.25 | 2023 | Signifor Lar, Isturisa |
| Aimmune Therapeutics, INC. | $17.90 | 2025 | Zenpep |
| Halozyme INC | $17.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vidhya Subramanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.